Publicaciones (76) Publicaciones de Santiago Ropero Salinas

2023

  1. Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2021

  1. Downregulation of snail by dusp1 impairs cell migration and invasion through the inactivation of jnk and erk and is useful as a predictive factor in the prognosis of prostate cancer

    Cancers, Vol. 13, Núm. 5, pp. 1-21

  2. The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments

    Cancers, Vol. 13, Núm. 9

2020

  1. Epigenetic regulation of gfi1 in endocrine-related cancers: A role regulating tumor growth

    International Journal of Molecular Sciences, Vol. 21, Núm. 13, pp. 1-12

2017

  1. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer

    APMIS, Vol. 125, Núm. 9, pp. 787-796

2016

  1. A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

    Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25

  2. Cancer detection and prognosis

    Nucleic Acid Testing for Human Disease (CRC Press), pp. 353-371

  3. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

    Molecular Diagnosis and Therapy, Vol. 20, Núm. 6, pp. 531-549

  4. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile

    Journal of Urology, Vol. 195, Núm. 3, pp. 619-626

  5. Epigenetics in schizophrenia: A pilot study of global dna methylation in different brain regions associated with higher cognitive functions

    Frontiers in Psychology, Vol. 7, Núm. SEP

  6. Erratum: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function (Nature Genetics (2009) 41 (365-370))

    Nature Genetics

  7. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade

    Pathology Research and Practice, Vol. 212, Núm. 10, pp. 899-903

2015

  1. DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment

    International Journal of Geriatric Psychiatry, Vol. 30, Núm. 6, pp. 558-565

2014

  1. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis

    Prostate, Vol. 74, Núm. 12, pp. 1171-1182

  2. DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma

    BMC Cancer, Vol. 14, Núm. 1

  3. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract

    Actas Urologicas Espanolas, Vol. 38, Núm. 9, pp. 600-607

  4. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism

    Molecular Oncology, Vol. 8, Núm. 1, pp. 27-38

2013

  1. The study of DNA methylation in urological cancer: Present and future

    Actas Urologicas Espanolas

2012

  1. A DNA methylation fingerprint of 1628 human samples

    Genome Research, Vol. 22, Núm. 2, pp. 407-419

2011

  1. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 11, pp. 4394-4399